Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Clinical trial NCT00988429 · COMPLETED

Trial details

NCT number: NCT00988429
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2008-12-02
Primary completion: 2012-01-12
Enrollment: 653

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.